A Gene Transfer Therapy to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) Following Therapeutic Plasma Exchange (Plasmapheresis) in Participants With Duchenne Muscular Dystrophy (DMD) and Pre-existing Antibodies to AAVrh74
Clinical trial NCT06597656 · TERMINATED
Trial details
- NCT number
- NCT06597656
- Sponsor
- Sarepta Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-18
- Primary completion
- 2025-08-05
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.